• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy programs will be updated November 1, 2023:

Effective November 1, 2023:

  • Jynarque

Effective December 1, 2023:

  • Rystiggo
  • Continuous Glucose Monitoring Systems (CGM)
  • Insulin Pump
  • Tezspire
  • SA Oncology
  • PCSK9 Inhibitors
  • Bempedoic Acid
  • Cholestasis Pruritis
  • Weight Loss Agents
  • Zorvye
  • IL-4 Inhibitor
  • IL-13 Antagonist
  • Cibinqo  
  • Biologic Immunomodulators

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.

Institutional Providers
Professional Providers